Accelerate biotechnology

Timeline Stories

10-year anniversary

We are celebrating! Ten years ago, Chris Yallop and Menzo Havenga incorporated Batavia Biosciences at the chamber of commerce in the Netherlands. The company started operations on January 1, 2010 at that time with 7 employees.


Expansion viral vector and GMP facilities

Announcement of the 4,000 ft2 expansion of the viral vector process development facilities in the USA and GMP clean room facilities in the Netherlands to accommodate the increasing market demand.


100 employees

Batavia Biosciences hires its 100th employee! The company is proud to have a highly educated and very experienced staff.


Moving to new facility NL

To accommodate the fast growth, Batavia Biosciences needed a new facility in the Netherlands. Therefore, a brand new, state of the art, office and laboratory infrastructure (65,000 ft2) was built just across the street of the old location at the Leiden BioScience Park.


Bioservices becomes Biosciences

Batavia Bioservices changes its name to Batavia Biosciences. The new name better reflects the added value and scientific support that we bring to our sponsors as well as our R&D staff’s efforts in developing exciting novel technologies to accelerate biopharmaceutical product development.


Launch of US subsidiary

Batavia Bioservices Inc. launches laboratory infrastructure in the Greater Boston area. 10,000 ft2 of dedicated BSL-2 laboratories are fully equipped to accommodate the increasing market demand from the US.


Acquisition of Xendo Manufacturing B.V.

The acquisition gave Batavia access to simulated moving bed purification technology as well as infrastructure, and microbial process and product development. With the acquisition the company had doubled its staff.


The company was founded

Menzo Havenga and Chris Yallop founded, what was then still called, Batavia Bioservices. With a staff of 7 dedicated people, vaccine and therapeutic protein projects for the first customers were executed.

COVID-19 Message

Please read the message from our executive management regarding the precautionary measures at Batavia Biosciences.